Novakand Pharma AB (publ) (FRA:3EE0)
Germany
· Delayed Price · Currency is EUR 0.0001
0.00 (0.00%)
At close: Dec 5, 2025
Novakand Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 22.27 | 46.36 | 45.69 | 95.15 | 106.52 | 55.01 | Upgrade
|
| Cash & Short-Term Investments | 22.27 | 46.36 | 45.69 | 95.15 | 106.52 | 55.01 | Upgrade
|
| Cash Growth | -61.56% | 1.47% | -51.98% | -10.68% | 93.65% | 364.28% | Upgrade
|
| Accounts Receivable | - | - | - | - | 5.28 | - | Upgrade
|
| Other Receivables | 0.61 | 1.54 | 1.24 | 0.86 | - | 1.1 | Upgrade
|
| Receivables | 0.61 | 1.54 | 1.24 | 0.86 | 5.28 | 1.1 | Upgrade
|
| Prepaid Expenses | 0.31 | 1.01 | 0.71 | 0.97 | - | 0.28 | Upgrade
|
| Other Current Assets | - | - | - | 2.51 | - | 4.79 | Upgrade
|
| Total Current Assets | 23.19 | 48.91 | 47.64 | 99.49 | 111.8 | 61.17 | Upgrade
|
| Property, Plant & Equipment | - | - | - | 0.25 | 0.61 | 0.93 | Upgrade
|
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Intangible Assets | - | 18 | 18 | 21 | 21 | 21 | Upgrade
|
| Other Long-Term Assets | - | - | - | - | -0 | - | Upgrade
|
| Total Assets | 23.19 | 66.91 | 65.64 | 120.74 | 133.41 | 83.1 | Upgrade
|
| Accounts Payable | - | 2.67 | 2.75 | 3.33 | 3.6 | 2.41 | Upgrade
|
| Accrued Expenses | 1.64 | 1.28 | 14.66 | 6.74 | 6.7 | 3.85 | Upgrade
|
| Current Portion of Leases | - | - | - | - | 0.13 | 0.34 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | - | 3.24 | Upgrade
|
| Other Current Liabilities | 1.52 | 0.67 | 0.57 | 3.76 | - | - | Upgrade
|
| Total Current Liabilities | 3.16 | 4.61 | 17.98 | 13.83 | 10.43 | 9.84 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 0.45 | Upgrade
|
| Long-Term Leases | - | - | - | - | 0.44 | 0.53 | Upgrade
|
| Other Long-Term Liabilities | 0 | - | - | - | -0 | - | Upgrade
|
| Total Liabilities | 3.16 | 4.61 | 17.98 | 13.83 | 10.87 | 10.82 | Upgrade
|
| Common Stock | 11.78 | 11.78 | 7.92 | 66.27 | 46.79 | 39.52 | Upgrade
|
| Additional Paid-In Capital | 458.82 | 460.92 | 405.57 | 401.58 | 384.21 | 295.54 | Upgrade
|
| Retained Earnings | -450.57 | -410.4 | -365.83 | -360.94 | -308.46 | -262.77 | Upgrade
|
| Comprehensive Income & Other | - | - | - | 0 | -0 | - | Upgrade
|
| Shareholders' Equity | 20.03 | 62.3 | 47.67 | 106.91 | 122.54 | 72.28 | Upgrade
|
| Total Liabilities & Equity | 23.19 | 66.91 | 65.64 | 120.74 | 133.41 | 83.1 | Upgrade
|
| Total Debt | - | - | - | - | 0.57 | 1.32 | Upgrade
|
| Net Cash (Debt) | 22.27 | 46.36 | 45.69 | 95.15 | 105.95 | 53.69 | Upgrade
|
| Net Cash Growth | -61.56% | 1.47% | -51.98% | -10.20% | 97.36% | - | Upgrade
|
| Net Cash Per Share | 0.18 | 0.40 | 0.57 | 1.64 | 1.89 | 1.48 | Upgrade
|
| Filing Date Shares Outstanding | 121.19 | 121.19 | 81.51 | 79.53 | 56.14 | 47.42 | Upgrade
|
| Total Common Shares Outstanding | 121.19 | 121.19 | 81.51 | 79.53 | 56.14 | 47.42 | Upgrade
|
| Working Capital | 20.03 | 44.3 | 29.66 | 85.66 | 101.37 | 51.33 | Upgrade
|
| Book Value Per Share | 0.17 | 0.51 | 0.58 | 1.34 | 2.18 | 1.52 | Upgrade
|
| Tangible Book Value | 20.03 | 44.3 | 29.67 | 85.91 | 101.54 | 51.28 | Upgrade
|
| Tangible Book Value Per Share | 0.17 | 0.37 | 0.36 | 1.08 | 1.81 | 1.08 | Upgrade
|
| Machinery | - | - | - | 0.06 | 0.06 | 0.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.